Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning

[1]  Nikolas Dovrolis,et al.  Laying in silico pipelines for drug repositioning: a paradigm in ensemble analysis for neurodegenerative diseases. , 2017, Drug discovery today.

[2]  G. Pond,et al.  Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials , 2017, Oncotarget.

[3]  Zheng Guo,et al.  Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms , 2016, Oncotarget.

[4]  Kathleen M Jagodnik,et al.  Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd , 2016, Nature Communications.

[5]  Soo-Youl Kim,et al.  Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion , 2016, Oncotarget.

[6]  Giovanni Coppola,et al.  A Systems-Level Analysis of the Peripheral Nerve Intrinsic Axonal Growth Program , 2016, Neuron.

[7]  D. Ettinger,et al.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  Libin Chen,et al.  Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer , 2016, Briefings Bioinform..

[9]  Wolfgang Huber,et al.  A chemical–genetic interaction map of small molecules using high‐throughput imaging in cancer cells , 2015, Molecular systems biology.

[10]  Sheng Wei,et al.  Targeting oncogenic KRAS in non-small cell lung cancer cells by phenformin inhibits growth and angiogenesis. , 2015, American journal of cancer research.

[11]  Livia Perfetto,et al.  SIGNOR: a database of causal relationships between biological entities , 2015, Nucleic Acids Res..

[12]  Diego di Bernardo,et al.  Drug-set enrichment analysis: a novel tool to investigate drug mode of action , 2015, Bioinform..

[13]  Zheng Guo,et al.  Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments , 2015, Scientific Reports.

[14]  Jia Wang,et al.  Synergistic Effect of Phenformin in Non-Small Cell Lung Cancer (NSCLC) Ionizing Radiation Treatment , 2015, Cell Biochemistry and Biophysics.

[15]  Pankaj Agarwal,et al.  Systematic evaluation of connectivity map for disease indications , 2014, Genome Medicine.

[16]  Robert Petryszak,et al.  ArrayExpress update—simplifying data submissions , 2014, Nucleic Acids Res..

[17]  Jean-Pierre A. Kocher,et al.  A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis , 2013, Bioinform..

[18]  Robert Tibshirani,et al.  Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data , 2013, Statistical methods in medical research.

[19]  Erika Martinelli,et al.  Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines , 2013, Clinical Cancer Research.

[20]  F. Iorio,et al.  Transcriptional data: a new gateway to drug repositioning? , 2013, Drug discovery today.

[21]  Liu Wei,et al.  LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. , 2013, Cancer cell.

[22]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[23]  Haiyang Xie,et al.  Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of human Hepatocellular Carcinoma , 2012, Molecular Cancer Therapeutics.

[24]  Jing Zhu,et al.  GO-function: deriving biologically relevant functions from statistically significant functions , 2012, Briefings Bioinform..

[25]  Alexander A. Morgan,et al.  Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.

[26]  Y. Luqmani,et al.  Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells , 2011, PloS one.

[27]  David M. Simcha,et al.  Tackling the widespread and critical impact of batch effects in high-throughput data , 2010, Nature Reviews Genetics.

[28]  S. Wacholder,et al.  Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.

[29]  J. Weinstein,et al.  Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses. , 2007, Cancer research.

[30]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[31]  Richard J. Fox,et al.  A two-sample Bayesian t-test for microarray data , 2006, BMC Bioinformatics.

[32]  Il-Jin Kim,et al.  Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays , 2004, Clinical Cancer Research.

[33]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[34]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[35]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A K Bahn,et al.  Application of binomial distribution to medicine: comparison of one sample proportion to an expected proportion (for small samples). Evaluation of a new treatment. Evaluation of a risk factor. , 1969, Journal of the American Medical Women's Association.

[37]  Qiang Sun,et al.  Individual-level analysis of differential expression of genes and pathways for personalized medicine , 2015, Bioinform..

[38]  Justin Lamb,et al.  The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.

[39]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[40]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[41]  Chi-Ying F. Huang,et al.  BMC Genomics BioMed Central Methodology article , 2008 .